Hunter J. Shkolnik
Our clients always come first. We combine strong trial advocacy with the unparalleled use of technology in order to give our clients the very best representation possible.
Contact Hunter J. Shkolnik
array(6) { [0]=> string(18) "https://natla.org/" [1]=> string(21) "https://www.avvo.com/" [2]=> bool(false) [3]=> string(29) "https://www.superlawyers.com/" [4]=> string(57) "https://www.martindale.com/ratings-and-reviews/consumers/" [5]=> string(31) "https://www.litigatorawards.com" }

Areas of Practice

Opioid Crisis Medical Malpractice Personal Injury Pharmaceutical Litigation Aviation Accidents View All Practice Areas

Hunter J. Shkolnik

Partner

Hunter J. Shkolnik is an esteemed and dedicated attorney who focuses on the trials of significant personal injury cases, primarily in the area of drug, automobile, aviation-related, and heavy truck product liability litigation.

He leads the discovery and trial teams of various mass tort pharmaceutical and medical device litigations for the Napoli Shkolnik PLLC law firm. He is also active in managing national litigation and plaintiff litigation groups including the American Association of Justice’s Actos Litigation Group.

He is currently serving as a chairman, leader, or court-appointed representative on Plaintiff Steering Committees in various drug and other mass torts. Additionally, Mr. Shkolnik has also held officer positions in the New York State Trial Lawyers, Nassau County Bar Association and Committee Chair positions in ATLA Health Care Finance Litigation Group, Orthopedic Implant Litigation Group, AAJ Breast Cancer Litigation Group, Co-Chair AAJ Heart Device Litigation Group, and the Chair of the Medtronic ICD and CRTD Litigation Sub Group.

Mr. Shkolnik has also lectured and organized seminars on issues involving Guidant, Medtronic, and St. Jude pacemakers; ICD and lead wire recall science and litigation; cardiac device product liability litigation; class action topics such as Ethics of Mass Tort Settlements, Lone Pine, State Federal Coordination and Preemption; and has — on multiple occasions — lectured on the science related to various pharmaceuticals.